4 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 30.1% per year over the past 3 years.
Net income has grown slower than revenue (8.4% vs 30.1% per year).
Operating margin has contracted, at 5.9% in the latest year.
Financial health
Total debt ($353M) exceeds cash ($197M); net debt is $156M.
Total debt has grown in line with revenue (28.9% vs 30.1% per year).
Operating income covered interest expense 11× in the latest year, up from 9.0× 3 years ago.
Total debt is 1.1× EBITDA.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$5.3B
$192M
0.0%
5.9%
20.2%
3.4%
—
$353M
$197M
2024
$4.1B
$56M
0.0%
3.0%
7.9%
1.1%
—
$412M
$158M
2023
$3.1B
$113M
0.0%
6.7%
117.4%
3.2%
—
$213M
$73M
2022
$2.4B
$150M
0.0%
9.6%
—
—
—
—
$58M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$1.4B
$76M
0.0%
7.7%
6.9%
1.4%
—
$246M
$164M
Mar '26
$1.4B
$81M
0.0%
8.5%
7.8%
1.4%
—
$248M
$248M
Dec '25
$1.4B
$60M
0.0%
7.0%
6.3%
1.1%
—
$353M
$197M
Sep '25
$1.3B
$52M
0.0%
6.4%
6.0%
0.9%
—
$253M
$356M
Jun '25
$1.3B
$51M
0.0%
6.2%
6.3%
0.9%
—
$257M
$294M
Mar '25
$1.3B
$28M
0.0%
3.8%
3.8%
0.5%
—
$262M
$288M
Dec '24
$1.2B
$37M
0.0%
6.0%
5.2%
0.7%
—
$412M
$158M
Sep '24
$1.0B
$16M
17.1%
2.2%
2.4%
0.3%
—
$269M
$50M
Jun '24
$935M
-$32M
18.5%
-4.0%
-5.9%
-0.8%
—
$243M
$73M
Mar '24
$919M
$35M
19.9%
7.1%
30.6%
0.9%
—
$248M
$81M
Dec '23
$853M
$34M
0.0%
7.3%
35.5%
1.0%
—
$213M
$73M
Sep '23
$789M
$20M
19.1%
4.6%
—
—
—
—
$69M
Jun '23
$760M
$21M
22.3%
6.5%
—
—
—
—
$38M
Mar '23
$708M
$38M
23.9%
8.4%
—
—
—
—
$94M
Valuation over time
How the market has priced PACS against its own fundamentals since 2024-04 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 35.0× (Apr '24) to 37.7× (Nov '26).
The price-to-sales ratio has risen from 1.3× (Apr '24) to 1.4× (Nov '26).
The dividend yield has fallen from 2.0% (Apr '24) to 0.6% (Nov '25).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is PACS growing its revenue and profit?
Over the past 3 years, Pacs Group, Inc.'s revenue has grown 30.1% per year, and net income grown 8.4% per year. These are computed facts, not advice.
How much debt does PACS have?
As of FY2025, Pacs Group, Inc. reported $353M of total debt against $197M of cash; operating income covered interest expense 11×.
What is PACS's profit margin?
In FY2025, gross margin was —, operating margin 5.9%, and net margin 3.6%.
What is PACS's P/E ratio?
Pacs Group, Inc.'s P/E (TTM) is 26.82 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the PACS stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 37.7× as of Nov '26) can differ. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.